Psychiatry
1 drug is in development for Bipolar Disorder.
- Companies
- 1
- Clinical trials
- 20
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Bipolar Disorder pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| azetukalner | Xenon Pharmaceuticals Inc. (XENE) |
About this indication
Bipolar Disorder context
Psychiatry·MeSH: Bipolar Disorder (D001714)
Also known as: Bipolar Affective Psychosis, Bipolar Disorders, Bipolar Mood Disorders, Depression, Manic, Depressions, Manic, Disorder, Bipolar Mood, Manic Depressive Psychosis, Psychoses, Bipolar Affective, Psychoses, Manic Depressive
Prevalence
463.1 / 100K
Incidence
32.5 / 100K/yr
Frequently asked questions
How many drugs are in development for Bipolar Disorder?
BioSniper tracks 1 drug in development for Bipolar Disorder across 1 company.
How many clinical trials target Bipolar Disorder?
There are 20 clinical trials targeting Bipolar Disorder tracked by BioSniper.
What is the prevalence of Bipolar Disorder?
The estimated prevalence of Bipolar Disorder is approximately 463.1 per 100,000 population.